Only One Splice Variant of the Human TAZ Gene Encodes a Functional Protein with a Role in Cardiolipin Metabolism

Frédéric M. Vaz, Riekelt H. Houtkooper, Fredoen Valianpour, P. G. Barth, Ronald J. A. Wanders

Journal of Biological Chemistry · 2003 · 136 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

Barth syndrome (BTHS) is an X-linked recessive disorder caused by mutations in the TAZ gene and is characterized by cardiomyopathy, short stature, neutropenia, and 3-methylglutaconic aciduria. Recently it was found that BTHS patients exhibit a profound cardiolipin deficiency although the biosynthetic capacity to synthesize this lipid from its precursor phosphatidylglycerol is entirely normal. Like BTHS patients, a Saccharomyces cerevisiae strain, in which the yeast orthologue of the human TAZ gene has been disrupted, exhibits an abnormal cardiolipin profile as determined by tandem mass spectrometry. Additionally, this yeast strain grows poorly on non-fermentable carbon sources. We have used both properties of this yeast disruptant as a read-out system to test the physiological functionality of each of 12 different splice variants that have been reported for the human TAZ gene. Our results demonstrate that only the splice variant lacking exon 5 was able to complement the retarded growth of the yeast disruptant on selective plates and restore the cardiolipin profile to the wild type pattern. We conclude that this splice variant most likely represents the only physiologically important mRNA, at least with regard to cardiolipin metabolism. Barth syndrome (BTHS) is an X-linked recessive disorder caused by mutations in the TAZ gene and is characterized by cardiomyopathy, short stature, neutropenia, and 3-methylglutaconic aciduria. Recently it was found that BTHS patients exhibit a profound cardiolipin deficiency although the biosynthetic capacity to synthesize this lipid from its precursor phosphatidylglycerol is entirely normal. Like BTHS patients, a Saccharomyces cerevisiae strain, in which the yeast orthologue of the human TAZ gene has been disrupted, exhibits an abnormal cardiolipin profile as determined by tandem mass spectrometry. Additionally, this yeast strain grows poorly on non-fermentable carbon sources. We have used both properties of this yeast disruptant as a read-out system to test the physiological functionality of each of 12 different splice variants that have been reported for the human TAZ gene. Our results demonstrate that only the splice variant lacking exon 5 was able to complement the retarded growth of the yeast disruptant on selective plates and restore the cardiolipin profile to the wild type pattern. We conclude that this splice variant most likely represents the only physiologically important mRNA, at least with regard to cardiolipin metabolism. Barth syndrome (BTHS 1The abbreviations used are: BTHS, Barth syndrome; HTAZ, human tafazzin; YTAZ, yeast tafazzin.; MIM 302060) is an X-linked recessive disorder, which clinically is characterized by cardiomyopathy, skeletal myopathy, growth retardation, and neutropenia. Additional laboratory findings include intermittent lactic acidemia, low blood cholesterol, and increased urinary excretion of 3-methylglutaconic acid, 3-methylglutaric acid, and 2-ethylhydracrylic acid (1Barth P.G. Wanders R.J. Vreken P. Janssen E.A. Lam J. Baas F. J. Inherited Metab. Dis. 1999; 22: 555-567Crossref PubMed Scopus (114) Google Scholar). Moreover, mitochondria of BTHS patients have an abnormal ultrastructure, and several different respiratory chain defects in muscle and fibroblasts have been reported (1Barth P.G. Wanders R.J. Vreken P. Janssen E.A. Lam J. Baas F. J. Inherited Metab. Dis. 1999; 22: 555-567Crossref PubMed Scopus (114) Google Scholar). The disease is often fatal in childhood because of cardiac failure or sepsis. The clinical expression of the disease, however, is quite variable in severity and may show profound intrafamilial variability (1Barth P.G. Wanders R.J. Vreken P. Janssen E.A. Lam J. Baas F. J. Inherited Metab. Dis. 1999; 22: 555-567Crossref PubMed Scopus (114) Google Scholar, 2Orstavik K.H. Orstavik R.E. Naumova A.K. D'Adamo P. Gedeon A. Bolhuis P.A. Barth P.G. Toniolo D. Am. J. Hum. Genet. 1998; 63: 1457-1463Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar, 3Johnston J. Kelley R.I. Feigenbaum A. Cox G.F. Iyer G.S. Funanage V.L. Proujansky R. Am. J. Hum. Genet. 1997; 61: 1053-1058Abstract Full Text Full Text PDF PubMed Scopus (117) Google Scholar). The TAZ gene (previously known as G4.5), which is mutated in this disorder, is located on Xq28 (4Bolhuis P.A. Hensels G.W. Hulsebos T.J. Baas F. Barth P.G. Am. J. Hum. Genet. 1991; 48: 481-485PubMed Google Scholar) and is postulated to contain 11 exons based on the alignment of cDNA sequences with genomic data (5Bione S. D'Adamo P. Maestrini E. Gedeon A.K. Bolhuis P.A. Toniolo D. Nat. Genet. 1996; 12: 385-389Crossref PubMed Scopus (625) Google Scholar). At the transcriptional level, six different mRNAs have been identified containing different combinations of exons 5–7 because of differential splicing. Two variants containing either all three exons or lacking exon 5 are consistently more abundant in most tissues examined (5Bione S. D'Adamo P. Maestrini E. Gedeon A.K. Bolhuis P.A. Toniolo D. Nat. Genet. 1996; 12: 385-389Crossref PubMed Scopus (625) Google Scholar). Alternative splicing also has been reported to produce two different 5′-ends of the transcripts leading to two possible translation initiation sites (1st ATG at position 1–3 and 2nd ATG at position 277–279 of the full-length open reading frame). As a consequence, there are at least 12 possible mRNAs, which are present in different amounts in different tissues (5Bione S. D'Adamo P. Maestrini E. Gedeon A.K. Bolhuis P.A. Toniolo D. Nat. Genet. 1996; 12: 385-389Crossref PubMed Scopus (625) Google Scholar). Whether these splice variants all give rise to functional proteins awaited the identification of the physiological function of the encoded tafazzins, which has not been established so far. In 1997, Neuwald (6Neuwald A.F. Curr. Biol. 1997; 7: R465-R466Abstract Full Text Full Text PDF PubMed Google Scholar) hypothesized that tafazzins share homology with a family of acyltransferases that are involved in phospholipid metabolism. In line with this hypothesis, our group found abnormal levels of cardiolipin and phosphatidylglycerol in BTHS cells, whereas all other phospholipid classes are normal (7Vreken P. Valianpour F. Nijtmans L.G. Grivell L.A. Plecko B. Wanders R.J. Barth P.G. Biochem. Biophys. Res. Commun. 2000; 279: 378-382Crossref PubMed Scopus (310) Google Scholar). Cardiolipin is an acidic polyglycerophospholipid, which is almost exclusively found in the inner mitochondrial membrane and is synthesized from phosphatidylglycerol (8Hatch G.M. Int. J. Mol. Med. 1998; 1: 33-41PubMed Google Scholar). The structure of cardiolipin is shown in Fig. 1. After synthesis of cardiolipin, its fatty acid side chains are remodeled by a deacylation-reacylation cycle to obtain different cardiolipin species, which contain mainly mono-unsaturated and di-unsaturated chains of 16–18 carbons in length (8Hatch G.M. Int. J. Mol. Med. 1998; 1: 33-41PubMed Google Scholar). Cardiolipin is required for optimal functioning of the respiratory chain complexes and several other mitochondrial inner membrane proteins, including the ATP/ADP transporter and the carnitine acylcarnitine translocase (9Koshkin V. Greenberg M.L. Biochem. J. 2000; 347: 687-691Crossref PubMed Scopus (110) Google Scholar, 10Kadenbach B. Mende P. Kolbe H.V. Stipani I. Palmieri F. FEBS Lett. 1982; 139: 109-112Crossref PubMed Scopus (114) Google Scholar, 11Robinson N.C. J. Bioenerg. Biomembr. 1993; 25: 153-163Crossref PubMed Scopus (228) Google Scholar, 12Noel H. Pande S.V. Eur. J. Biochem. 1986; 155: 99-102Crossref PubMed Scopus (86) Google Scholar). Investigations in cultured skin fibroblasts of BTHS patients showed that the rate of biosynthesis of cardiolipin from phosphatidylglycerol is normal but that the cardiolipin pool size is considerably reduced as compared with control cells. Furthermore, the incorporation of linoleic acid, which is the characteristic acyl side chain found in mammalian cardiolipin, into both phosphatidylglycerol and cardiolipin was significantly reduced (7Vreken P. Valianpour F. Nijtmans L.G. Grivell L.A. Plecko B. Wanders R.J. Barth P.G. Biochem. Biophys. Res. Commun. 2000; 279: 378-382Crossref PubMed Scopus (310) Google Scholar). These results suggest that the TAZ gene encodes one or more acyltransferases involved in the remodeling of cardiolipin or its precursors. Direct evidence that the tafazzins are involved in cardiolipin metabolism was unavailable until now. DNA Manipulations—The 12 TAZ splice variants were amplified by PCR from primary human fibroblast cDNA using the following primers: two KpnI-tagged forward primers 5′-GGT ACC ATG CCT CTG CAC GTG AAG T-3′ and 5′-GGT ACC ATG GAC GAC CCT CAT CTC TG-3′ for the first (position 1–3) and the second (position 277–279) translation initiation site, respectively, and a SalI-tagged reverse primer 5′-GTC GAC CTA TCT CCC AGG CTG GAG GTG-3′. As described previously (5Bione S. D'Adamo P. Maestrini E. Gedeon A.K. Bolhuis P.A. Toniolo D. Nat. Genet. 1996; 12: 385-389Crossref PubMed Scopus (625) Google Scholar), five PCR products were observed on agarose gel, which subsequently were subcloned in the pGEM-T vector (Promega). Inserts were sequenced to exclude sequence errors introduced by Taq polymerase, and the different splice variants were cloned downstream of the yeast PGK promoter into the KpnI and SalI sites of the yeast expression vector pYPGK18. This vector is derived from the pHVXII vector (13Swiegers J.H. Vaz F.M. Pretorius I.S. Wanders R.J. Bauer F.F. FEMS Microbiol. Lett. 2002; 210: 19-23PubMed Google Scholar) after replacing the original multiple cloning site by that of pUC18. Yeast tafazzin (YTAZ) was amplified from W303 genomic DNA using a KpnI-tagged forward primer 5′-GGT ACC ATG TCT TTT AGG GAT GTC CTA G-3′ and a SalI-tagged reverse primer 5′-GTC GAC TCA ATC ATC CTT ACC CTT TGG-3′ and cloned into the KpnI and SalI sites of pYPGK18. The insert was sequenced to exclude sequence errors. Generation of the YPR140w Disruptant—To construct the Δtaz deletion mutant, the entire YPR140w open reading frame was replaced by the kanMX4 marker gene (14Wach A. Yeast. 1996; 12: 259-265Crossref PubMed Scopus (705) Google Scholar). The PCR-derived construct for disruption consisted of the kanMX4 gene flanked by short regions of homology corresponding to the YPR140w 3′ and 5′ non-coding regions. pKan was used as template with the YPR140w primers (5′-ATG TCT TTT AGG GAT GTC CTA GAA AGA GGA GAT GAA TTT TTA GAA GCC TAG CGT ACG CTG CAG GTC GAC-3′ and 5′-TCA ATC ATC CTT ACC CTT TGG TTT ACC CTC TGG AGG CAG AAA CTT TTG ATC GAT GAA TTC GAG CTC G-3′). The resulting PCR fragments were introduced into Saccharomyces cerevisiae wild type W303 strain (15Mashkevich G. Repetto B. Glerum D.M. Jin C. Tzagoloff A. J. Biol. Chem. 1997; 272: 14356-14364Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar). G418-resistant clones were selected by growth on YPD plates containing G418 (200 mg/liter) (14Wach A. Yeast. 1996; 12: 259-265Crossref PubMed Scopus (705) Google Scholar). Expression of TAZ Splice Variants and Complementation Analysis—The different pYPGK18 constructs were transformed to Δtaz using the lithium acetate procedure (16Becker D.M. Guarente L. Guthrie C. Fink G.R. Guide to Yeast Genetics and Molecular Biology. Academic Press, Inc., San Diego1991: 182-187Google Scholar). Transformed yeast cells were grown on minimal glucose medium (0.67% yeast nitrogen base, 2% glucose) at 30 °C and harvested in mid-exponential phase. For the complementation analysis, transformants were streaked on rich ethanol plates (2% peptone, 1% yeast extract, 2% agar, and 2% ethanol) and incubated at 37 °C for 1 week. For cardiolipin and immunoblot analysis, spheroplasts were prepared using zymolyase according to Franzusoff et al. (17Franzusoff A. Rothblatt J. Schekman R. Guthrie C. Fink G.R. Guide to Yeast Genetics and Molecular Biology. Academic Press, Inc., San Diego1991: 662-674Google Scholar) and lysed in a 10 mm sodium phosphate buffer, pH 7.4, containing 140 mm NaCl and protease inhibitor mixture (Roche Applied Science). After sonication, protein determination was performed by the method of Bradford (18Bradford M.M. Anal. Biochem. 1976; 72: 248-254Crossref PubMed Scopus (217544) Google Scholar). Cardiolipin Analysis by High Pressure Liquid Chromatography Tandem Mass Spectrometry—Lipids were extracted using a modification of the method of Folch et al. (19Folch J. Lees M. Stanley G.M. J. Biol. Chem. 1957; 226: 497-509Abstract Full Text PDF PubMed Google Scholar). Briefly, 0.4 nmol of CL(C14: 0)4 (Avanti Polar Lipids, Alabaster, AL) was added to the equivalent of 1 mg of protein in a total volume of 1 ml of distilled water, and this aqueous phase was extracted twice with 3 ml of chloroform/methanol (2:1 v/v) followed by centrifugation at 1000 × g. The combined organic phases were evaporated under a nitrogen stream, and the residue was taken up in 100 μl of chloroform/methanol/water (50:45:5 v/v/v) containing 2.5 ml/liter NH4OH. Five microliters of this lipid extract was injected into a straight-phase high pressure liquid chromatography system, and cardiolipin analysis was performed by on-line electrospray tandem mass spectrometry as described previously (20Valianpour F. Wanders R.J. Barth P.G. Overmars H. van Gennip A.H. Clin. Chem. 2002; 48: 1390-1397Crossref PubMed Scopus (104) Google Scholar). By using bovine heart monolysocardiolipin (consisting mostly of trilinoleylmonolysocardiolipin, Avanti Polar Lipids, Alabaster, AL), we determined that with this method monolysocardiolipins elute about 0.2 min later than the cardiolipins. For the acquisition of the cardiolipin spectra of both cardiolipins and monolysocardiolipins, a continuous negative scan was made from 400 to 1000 m/z in a time window of 2.5 min, during which both types of compounds elute from the column. In a separate analysis, using the same extract, single ion monitoring was used to quantify selected monolysocardiolipins and cardiolipins. The area of each (monolyso)cardiolipin peak (A (ml)cl) and that of the added internal standard (A IS) was quantified using MassLynx 3.3 (Micromass, Manchester, UK). The amount of (monolyso)cardiolipins was calculated by the formula: (A (ml)cl/A IS) × 0.4 nmol (the amount of internal standard added). These data were used to calculate the relative cardiolipin and monolysocardiolipin levels (Fig. 4) in comparison to wild type levels. Tafazzin Antibody Generation—The portion of the TAZ cDNA corresponding to exons 8–11 was amplified by PCR from human fibroblast cDNA using Taq polymerase and the following primers: a BamHI-tagged forward primer 5′-GGA TCC ATC GGG CGC CTG ATT GCT GAG-3′ and an HindIII-tagged reverse primer 5′-AAG CTT CTA TCT CCC AGG CTG GAG GTG-3′. The PCR product was cloned downstream of the isopropyl-1-thio-β-d-galactopyranoside-inducible PTAC promoter into the BamHI and HindIII sites of the bacterial expression vector pMAL-C2X, to express the last 98 amino acids of tafazzin fused to maltose-binding protein. This protein sequence is present in all of the protein products of the putative splice variants of the TAZ gene. The insert was sequenced to exclude sequence errors introduced by PCR, after which the construct was transformed to the Escherichia coli strain BL21. Protein expression, purification, and antibody generation was performed as described previously (21Vaz F.M. R. Wanders R.J. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). For of the the same tafazzin was cloned downstream of the isopropyl-1-thio-β-d-galactopyranoside-inducible PTAC promoter into the BamHI and HindIII sites of the bacterial expression vector in to express it as a to This protein was to and used for of the as described previously S. M. Wanders R.J. J. Res. 2002; Full Text Full Text PDF PubMed Google Scholar). This resulting antibody was for which was performed according to Vaz et al. (21Vaz F.M. R. Wanders R.J. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). the functionality of the different human splice variants of the TAZ we have a strain of S. cerevisiae in which the yeast orthologue of the TAZ has been This yeast deletion strain is to on non-fermentable carbon as at 37 As in BTHS patients (7Vreken P. Valianpour F. Nijtmans L.G. Grivell L.A. Plecko B. Wanders R.J. Barth P.G. Biochem. Biophys. Res. Commun. 2000; 279: 378-382Crossref PubMed Scopus (310) Google Scholar, F. Wanders R.J. Barth P.G. Overmars H. van Gennip A.H. Clin. Chem. 2002; 48: 1390-1397Crossref PubMed Scopus (104) Google Scholar), Δtaz an abnormal cardiolipin Fig. the cardiolipin profile of wild type W303 strain and that of the disruption In each cardiolipin the peak with the m/z represents For the ion with m/z represents a cardiolipin containing acid acyl side the cardiolipin spectra shown in Fig. one in that cardiolipins are as which that the mass to of the cardiolipin mass and that the the ion peak and its first peak is the cardiolipin the has an m/z of This cardiolipin has one and represents cardiolipin with three acid acyl side chain and one acid acyl side The which an ion with m/z of cardiolipins with one and three fatty acyl side m/z represents cardiolipin containing one acid and three acid acyl side Fig. as observed for BTHS, cardiolipin are either or present in levels and that this yeast disruptant is a for In there is of monolysocardiolipins and which has not been observed in with regard to the cardiolipin the yeast is to that observed in BTHS patients, we used this yeast system to the functionality of the different TAZ splice variants by complementation a of the splice variants that were and the abbreviations used for Yeast tafazzin (YTAZ) was used as a control for the complementation constructs were transformed to including pYPGK18 which was used as a negative analysis using an antibody that we the of human tafazzin that the splice variants were (Fig. of the different splice variants and used initiation initiation exon exon exons 5 and exons and exons in a it was determined the transformants the to on ethanol plates at 37 Fig. that only the expression of and was able to complement the growth whereas transformants the other splice variants retarded in growth to cardiolipin analysis was performed in and this showed that all transformants the same cardiolipin profile as for and and which show either a or of the cardiolipin profile (Fig. By of the added internal the amount of the most abundant monolysocardiolipins and and that of the cardiolipins containing and acyl side chains and was determined and to the levels found in the wild type strain (Fig. The results in this that the also to a of the cardiolipin profile for and in to these two the a of the cardiolipin cardiolipin containing a of fatty acids m/z and m/z are whereas cardiolipin containing mostly fatty acids and m/z a to that of wild type (Fig. This of the cardiolipin profile is also by the monolysocardiolipin which in the transformants or are with wild type but in the are (Fig. our results suggest that only and are functional splice which are involved in cardiolipin metabolism. are several however, to represents a physiologically Fig. 5 a alignment of amino acids of with tafazzin of including and This sequence amino acids encoded by exon that of the sequences have sequence homology to this whereas in the sequences the amino acids encoded by exon 5 a high homology with all is observed (Fig. This is also at the genomic DNA level, as from analysis using the full-length human tafazzin as in the and data base, which all exon 5 This of homology with both and in with the of to restore the growth on selective and the of the cardiolipin profile that exon the of which was postulated on the of its in human splice is a of splicing and in not to a protein. This is also by the that of the different mutations that have been identified in the TAZ is located in exon 5 (Fig. K.H. Orstavik R.E. Naumova A.K. D'Adamo P. Gedeon A. Bolhuis P.A. Barth P.G. Toniolo D. Am. J. Hum. Genet. 1998; 63: 1457-1463Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar, 3Johnston J. Kelley R.I. Feigenbaum A. Cox G.F. Iyer G.S. Funanage V.L. Proujansky R. Am. J. Hum. Genet. 1997; 61: 1053-1058Abstract Full Text Full Text PDF PubMed Scopus (117) Google Scholar, S. D'Adamo P. Maestrini E. Gedeon A.K. Bolhuis P.A. Toniolo D. Nat. Genet. 1996; 12: 385-389Crossref PubMed Scopus (625) Google Scholar, R. F. S. S. J. Mol. Genet. Metab. 2002; PubMed Scopus Google Scholar, J. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, P. L. Gedeon A. Janssen E.A. S. Bolhuis P.A. Barth P.G. M. E. Orstavik K.H. E. Toniolo D. Am. J. Hum. Genet. 1997; 61: Full Text PDF PubMed Scopus Google Scholar, F. S. J. H. PubMed Scopus Google Scholar, S. M. J. Eur. J. Hum. Genet. PubMed Scopus Google Scholar, I. E. S. Hum. Genet. PubMed Scopus Google Scholar). The results from the complementation analysis also show that of the tafazzins from the second translation initiation site were able to complement the not This is in with the that patients with mutations in exons 1 and the second translation initiation site which is to used for the of the tafazzins, also from BTHS and not a compared with patients with mutations in exons J. Kelley R.I. Feigenbaum A. Cox G.F. Iyer G.S. Funanage V.L. Proujansky R. Am. J. Hum. Genet. 1997; 61: 1053-1058Abstract Full Text Full Text PDF PubMed Scopus (117) Google Scholar, S. D'Adamo P. Maestrini E. Gedeon A.K. Bolhuis P.A. Toniolo D. Nat. Genet. 1996; 12: 385-389Crossref PubMed Scopus (625) Google Scholar, J. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, P. L. Gedeon A. Janssen E.A. S. Bolhuis P.A. Barth P.G. M. E. Orstavik K.H. E. Toniolo D. Am. J. Hum. Genet. 1997; 61: Full Text PDF PubMed Scopus Google of mutations found in the human TAZ gene in BTHS that mutations have been identified in the sequence postulated to exon In by using a functional complementation we have that of all the different TAZ mRNAs splice variants reported only the variant lacking the postulated exon 5 sequence results in a physiologically functional involved in cardiolipin metabolism. These results have important for the of data of Moreover, the for at the physiological of the encoded tafazzin in cardiolipin We G. and L. Nijtmans for the generation of the yeast deletion strain and H. R. and S. for on the

References

24